FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Apr 24, 2019
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on April 24, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d47fd450-a1a8-4e3b-b651-8abab62724d6
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1089657
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Octapharma Plasma, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 30, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 25, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 24, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 976436 - 2016-06-30
- FDA Inspection 806330 - 2012-10-25
- FDA Inspection 614657 - 2009-09-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.